[go: up one dir, main page]

PL354698A1 - Środek farmaceutyczny do zapobiegania lub leczeniaŚrodek farmaceutyczny do zapobiegania lub leczenia chorób o podłożu autoimmunizacyjnym chorób o podłożu autoimmunizacyjnym - Google Patents

Środek farmaceutyczny do zapobiegania lub leczeniaŚrodek farmaceutyczny do zapobiegania lub leczenia chorób o podłożu autoimmunizacyjnym chorób o podłożu autoimmunizacyjnym

Info

Publication number
PL354698A1
PL354698A1 PL02354698A PL35469802A PL354698A1 PL 354698 A1 PL354698 A1 PL 354698A1 PL 02354698 A PL02354698 A PL 02354698A PL 35469802 A PL35469802 A PL 35469802A PL 354698 A1 PL354698 A1 PL 354698A1
Authority
PL
Poland
Prior art keywords
prevention
self
treatment
pharmaceutical compound
based diseases
Prior art date
Application number
PL02354698A
Other languages
English (en)
Other versions
PL204536B1 (pl
Inventor
MarianSzczepanik Marian Szczepanik
Original Assignee
MarianSzczepanik Marian Szczepanik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MarianSzczepanik Marian Szczepanik filed Critical MarianSzczepanik Marian Szczepanik
Priority to PL354698A priority Critical patent/PL204536B1/pl
Publication of PL354698A1 publication Critical patent/PL354698A1/pl
Publication of PL204536B1 publication Critical patent/PL204536B1/pl

Links

PL354698A 2002-06-24 2002-06-24 Zastosowanie białka zasadowego mieliny świnki morskiej (GPMBP) (54) do wytwarzania leku, do podawania naskórnego, do zapobiegania lub leczenia choroby stwardnienia rozsianego PL204536B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL354698A PL204536B1 (pl) 2002-06-24 2002-06-24 Zastosowanie białka zasadowego mieliny świnki morskiej (GPMBP) (54) do wytwarzania leku, do podawania naskórnego, do zapobiegania lub leczenia choroby stwardnienia rozsianego

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL354698A PL204536B1 (pl) 2002-06-24 2002-06-24 Zastosowanie białka zasadowego mieliny świnki morskiej (GPMBP) (54) do wytwarzania leku, do podawania naskórnego, do zapobiegania lub leczenia choroby stwardnienia rozsianego

Publications (2)

Publication Number Publication Date
PL354698A1 true PL354698A1 (pl) 2003-12-29
PL204536B1 PL204536B1 (pl) 2010-01-29

Family

ID=30768622

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354698A PL204536B1 (pl) 2002-06-24 2002-06-24 Zastosowanie białka zasadowego mieliny świnki morskiej (GPMBP) (54) do wytwarzania leku, do podawania naskórnego, do zapobiegania lub leczenia choroby stwardnienia rozsianego

Country Status (1)

Country Link
PL (1) PL204536B1 (pl)

Also Published As

Publication number Publication date
PL204536B1 (pl) 2010-01-29

Similar Documents

Publication Publication Date Title
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
PT2527342E (pt) Derivados do éster cíclico uk-2a úteis para a prevenção ou tratamento de doenças fúngicas
HUS1300073I1 (hu) Fluorszubsztituált omega-karboxiaril-difenil-karbamid betegségek és egyéb állapot kezelésére és megelõzésére
HRP20040906B1 (en) Bisphosphonic acid for the treatment and prevention of ostreoporosis
IL184124A0 (en) Medicaments for the treatment or prevention of fibrotic diseases
GB0329874D0 (en) Compounds useful for the treatment of diseases
IL175535A0 (en) Compositions for treatment of neurodegenerative diseases
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
EP1500401A4 (en) DRUGS FOR THE TREATMENT OF VASCULAR DISEASES
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
HUP0500199A3 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
AU2003264954A1 (en) Pharmaceutical composition for prevention and treatment of kidney diseases
GB0201025D0 (en) The treatment of degenerative diseases
IL159511A0 (en) Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor
PL354698A1 (pl) Środek farmaceutyczny do zapobiegania lub leczeniaŚrodek farmaceutyczny do zapobiegania lub leczenia chorób o podłożu autoimmunizacyjnym chorób o podłożu autoimmunizacyjnym
PL367634A1 (pl) Kompozycja farmaceutyczna, zawierająca związek trójcykliczny, do profilaktyki i leczenia chorób skóry
GB0100092D0 (en) Treatment of degenerative diseases
EP1488800A4 (en) MEDICINE FOR THE TREATMENT OF PROTOCOL DISEASES
AU2003266621A1 (en) Medicinal composition for treatment for or prevention of visceral pain
AU2002343085A1 (en) Tnf-alpha inhibitors for the treatment of hepatic diseases
EP1490048A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF RESPIRATORY DISEASES
GB0222282D0 (en) Therapeutic device for the treatment of symptons caused by diseases
AU2002950148A0 (en) Pharmaceutical composition for the treatment of skin conditions
TWI350752B (en) Pharmaceutical composition for the treatment of connective tissue disease

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120624